VYOME HOLDINGS, INC. Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities
VYOME HOLDINGS, INC. (HIND) reported Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2023-04-17
- VYOME HOLDINGS, INC. unrecognized tax benefits, increase resulting from settlements with taxing authorities for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Settlements with Taxing Authorities 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |